Browse Arkansas Code titles and sections
4-88-1002. Definitions.
Arkansas Code — all titles (historical 2020) · legal_authorities
4-88-1002. Definitions.
As used in this subchapter:
(1) “Pharmacist” means a licensed pharmacist as defined in § 17-92-101;
(2) “Pharmacists services” means products, goods, or services provided as a part of the practice of pharmacy as defined in § 17-92-101, to individuals who reside or are employed in this state;
(3) “Pharmacy” means the same as defined in § 17-92-101;
(4) “Pharmacy benefits manager” means an entity that administers or manages a pharmacy benefits plan or program;
(5) “Pharmacy benefits plan or program” means any plan or program that pays for, reimburses, covers the cost of, or otherwise provides for pharmacists services to individuals who reside or are employed in this state;
(6) “Provider choice” means an individual's choice of provider network, individual pharmacy or pharmacist, or method of delivery under a pharmacy benefits plan or program; and
(7) “Provider network” means a network of pharmacists or pharmacies that are authorized by a pharmacy benefits plan or program to provide pharmacists services.
Source: Arkansas Code — historical release 78 (November 6, 2020) · 4-88-1002
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.
Issuing source page ↗
Authority boundary: historical statutory source snapshot not current law.
Open the recorded source website ↗
Record provenance
Stable record: arkansas_code:legal_authorities:4-88-1002
Source file: gov.ar.code.title.04.odt
Pages: Not recorded – Not recorded
Passage SHA-256: ace6339dc07c52d081b5e79cd149db0deaad6bb49182fc74bd35353c300545ee
Source location: content.xml paragraph 34965
Stored source content
4-88-1002. Definitions.
As used in this subchapter:
(1) “Pharmacist” means a licensed pharmacist as defined in § 17-92-101;
(2) “Pharmacists services” means products, goods, or services provided as a part of the practice of pharmacy as defined in § 17-92-101, to individuals who reside or are employed in this state;
(3) “Pharmacy” means the same as defined in § 17-92-101;
(4) “Pharmacy benefits manager” means an entity that administers or manages a pharmacy benefits plan or program;
(5) “Pharmacy benefits plan or program” means any plan or program that pays for, reimburses, covers the cost of, or otherwise provides for pharmacists services to individuals who reside or are employed in this state;
(6) “Provider choice” means an individual's choice of provider network, individual pharmacy or pharmacist, or method of delivery under a pharmacy benefits plan or program; and
(7) “Provider network” means a network of pharmacists or pharmacies that are authorized by a pharmacy benefits plan or program to provide pharmacists services.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Arkansas Code — all titles (historical 2020) · legal_authorities
17-92-101. Definitions.
As used in this chapter:
(1) “Biological product” means a biological product as defined by 42 U.S.C. § 262(i)(1), as it existed on January 1, 2019;
(2) “Credentialing” means the issuance of or approval by the Arkansas State Board of Pharmacy of a credential issued to a pharmacist by an agency approved by the Arkansas State Board of Pharmacy certifying that the pharmacist has met the standards of competency established by the Arkansas State Board of Pharmacy for disease state management or other pharmacy services necessitating a credential;
(3) “Dentist” means a practitioner of dentistry duly licensed under the laws of this or some other state;
(4)(A) “Disease state management” means a strategy that utilizes a team-oriented, multidisciplinary approach to improve healthcare outcomes and quality of care, and when possible, to control healthcare cost through management of targeted chronic disease states.
(B) Disease state management focuses on improving health care from prevention to diagnosis and treatment to ongoing follow-up.
(C) Disease state management will involve, but not be limited to, patient education, self-care techniques, and outpatient drug therapy management pursuant to a patient care plan;
(5) “Drug” shall include all medicines and preparations recognized in the United States Pharmacopeia or the National Formulary as substances intended to be used for the care, mitigation, or prevention of disease of either man or other animals;
(6) “Generically equivalent” means a drug that is pharmaceutically and therapeutically equivalent to the drug prescribed;
(7) “Interchangeable biological product” means a biological product that is interchangeable as defined by 42 U.S.C. § 262(i)(3), as it existed on January 1, 2019;
(8)(A)
Source: Arkansas Code — historical release 78 (November 6, 2020) · 17-92-101
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. The source passage cites 17-92-101. This identifies an authority to review, not proof of applicability.